 |
市場調査レポート
商品コード
1373770
創薬サービスの世界市場 (2023-2030年)：タイプ (低分子・高分子)・エンドユーザー (製薬&バイオテクノロジー企業・学術機関) 別の規模・シェア・成長分析・予測Global Drug Discovery Services Market Size, Share, Growth Analysis, By Type(Small molecules and Large molecules), By End-User(Pharmaceutical & Biotechnology companies and Academic Institutes) - Industry Forecast 2023-2030 |
||||||
| 創薬サービスの世界市場 (2023-2030年)：タイプ (低分子・高分子)・エンドユーザー (製薬&バイオテクノロジー企業・学術機関) 別の規模・シェア・成長分析・予測 |
|
出版日: 2023年10月19日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の創薬サービスの市場規模は、2021年の32億6,000万米ドル、2022年の35億米ドルから、予測期間中は7.3%のCAGRで推移し、2030年には66億米ドルの規模に成長すると予測されています。
世界の創薬サービス市場の促進要因
さまざまな治療目的での新規治療に対する需要の高まり
- 慢性疾患に対する新規治療への需要の高まりと、世界のヘルスケア産業の進歩が市場拡大の主な要因になると予測されています。製薬企業やバイオ医薬品企業はR&D活動をCROに委託しているため、CROはR&Dサービスを提供し、R&Dの効率を最大化するためのエンゲージメントモデルを構築しています。また、政府や製薬企業は、慢性疾患による負担の増加から、ソリューションを模索し、臨床試験への投資を拡大する必要に迫られています。これらのことから、創薬サービスに対するニーズが拡大すると予測されています。
世界の創薬サービス市場の動向
- 市場には、その展望を形成するいくつかの主要な市場動向が見られます。第一に、製薬企業やバイオテクノロジー企業は創薬活動を行うために専門のサービスプロバイダーを求めるようになり、アウトソーシングが顕著に増加しています。そうすることで、企業はコアコンピタンスに集中しながら、専門知識、先端技術、コスト効率の高いソリューションを利用することができます。もう一つの重要な動向は、製薬企業とCROとの間の共同パートナーシップへのシフトです。このようなパートナーシップにより、リソース、専門知識、リスクの共有が可能になり、イノベーションが促進され、創薬プロセスが加速されます。創薬サービス市場では、技術の進歩が重要な役割を果たしています。ハイスループットスクリーニング、AI、ゲノミクスなどの技術が創薬プロセスに革命をもたらし、より迅速かつ効率的な創薬候補化合物の同定と最適化を可能にしています。
当レポートでは、世界の創薬サービスの市場を調査し、市場概要、市場への各種影響因子の分析、技術・イノベーションの動向、法規制環境、市場規模の推移・予測、各種区分・地域別の内訳、競合情勢、主要企業のプロファイルなどをまとめています。
目次
- エグゼクティブサマリー
- 調査手法
- 親市場の分析
- 市場概要
- 市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 主要な市場洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 貿易分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品の分析
- マクロ経済指標
- 主要投資分析
- 主要な成功要因
- 競合の程度
- 市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 市場力学
- 規制状況
- ポーターの分析
- 将来のディスラプションに関するSkyquestの特別な洞察
- 世界の創薬サービス市場：タイプ別
- 市場概要
- 低分子
- 高分子
- 世界の創薬サービス市場：エンドユーザー別
- 市場概要
- 製薬およびバイオテクノロジー企業
- 学術機関
- 世界の創薬サービス市場：地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
- 競合情勢
- トップ5社の比較
- 主要企業の市場での位置付け
- 主要企業の採用戦略
- 主要成功戦略
- 市場における最近の活動
- 主要企業の市場シェア
- 主要企業プロファイル
- General Electric
- Eurofins Scientific
- PPD Inc.
- Syngene International Limited
- Wuxi AppTec
- Frontage Labs
- Galapagos NV
- Aurigene Discovery Technologies
- Genscript
- Domainex
- WIL Research Laboratories LLC
- Shanghai Medicilon, Inc.
- Labcorp Drug Development
- Jubilant Biosys Ltd.
- Evotec
- Shanghai ChemPartner
- Charles River Laboratories
- Merck & Co. Inc.
- Thermo Fisher Scientific Inc.
- TCG Lifesciences Pvt Ltd.
Global Drug Discovery Services Market size was valued at USD 3.26 billion in 2021 and is poised to grow from USD 3.5 billion in 2022 to USD 6.6 billion by 2030, growing at a CAGR of 7.3% during the forecast period (2023-2030).
The Global Drug Discovery Services Market is a dynamic and rapidly evolving sector within the pharmaceutical and biotechnology industries. It encompasses a wide range of services and solutions aimed at discovering and developing new drugs to address various diseases and medical conditions. Drug discovery is a complex and resource-intensive process that involves the identification and validation of potential drug targets, the development of drug candidates, and rigorous testing for safety and efficacy. This process typically takes several years and requires significant investment in research and development (R&D). To streamline and expedite this process, pharmaceutical and biotechnology companies often seek the assistance of specialized drug discovery service providers. These service providers offer a diverse range of services to support the drug discovery process. They utilize advanced technologies, expertise, and infrastructure to accelerate the identification and optimization of potential drug candidates. These services may include target identification and validation, hit identification and lead optimization, medicinal chemistry, in vitro and in vivo testing, preclinical development, and early-phase clinical trials. In conclusion, the Global market plays a vital role in the drug development process, providing essential support and expertise to pharmaceutical and biotechnology companies. With the increasing demand for innovative therapies and the need for accelerated drug development, this market is expected to experience substantial growth in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Drug Discovery Services Market Segmental Analysis
Global Drug Discovery Services Market is segmented by type, end-user, and region. Based on type, the market can be segmented into small molecules and large molecules. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies and academic institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Drivers of the Global Drug Discovery Services Market
Rising demand for novel therapies for various therapeutic purposes
- Drug-finding services rising demand for novel treatments for chronic diseases and advancements in the global healthcare industry are predicted to be the main drivers of market expansion. Pharmaceutical and biopharmaceutical businesses still contract out their research and development (R&D) activities to CROs, which offer R&D services and create engagement models to maximise R&D efficiency. Governments and pharmaceutical corporations are being forced to look for solutions and boost their investment in clinical trials as a result of the increased burden of chronic diseases. As a result, there will be a greater need for drug discovery services.
Restraints in the Global Drug Discovery Services Market
High cost of drug molecules and lack of skilled labour
- The two biggest challenges facing the market will be a scarcity of trained labour and a high failure rate for target medication molecules. Millions of dollars are spent on preclinical research to find a molecule or create a medicine, which drives up the price of drug development.
Market Trends of the Global Drug Discovery Services Key
- Global Drug Discovery Services Market is experiencing several key market trends that are shaping its landscape. Firstly, there is a noticeable increase in outsourcing as pharmaceutical and biotech companies seek specialized service providers to handle their drug discovery activities. By doing so, companies can access expertise, advanced technologies, and cost-effective solutions while focusing on their core competencies. Another significant trend is the shift towards collaborative partnerships between pharmaceutical companies and contract research organizations (CROs). These partnerships allow for shared resources, expertise, and risk-sharing, fostering innovation and accelerating the drug discovery process. Technological advancements play a vital role in the drug discovery services market. Technologies such as high-throughput screening, artificial intelligence, and genomics are revolutionizing the process, enabling faster and more efficient identification and optimization of drug candidates.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Drug Discovery Services Market by Type
- Market Overview
- Small molecules and Large molecules
- Global Drug Discovery Services Market by End-User
- Market Overview
- Pharmaceutical & Biotechnology companies and Academic Institutes
- Global Drug Discovery Services Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- General Electric (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eurofins Scientific (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PPD Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Syngene International Limited (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Wuxi AppTec (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Frontage Labs (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Galapagos NV (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Aurigene Discovery Technologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genscript (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Domainex (U.K.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- WIL Research Laboratories LLC (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shanghai Medicilon, Inc. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Labcorp Drug Development (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jubilant Biosys Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Evotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shanghai ChemPartner (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Charles River Laboratories (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co. Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (U.S.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- TCG Lifesciences Pvt Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
